Handbook of Targeted Cancer Therapy and Immunotherapy, 2nd edition (PDF)

25 $

Delivery time: Maximum to 1 hours

Format : Publisher PDF

File Size : 33.7 MB

This book is a comprehensive yet concise reference with clinical trial results of over 190 targeted therapy and immunotherapy agents, including expanded immunotherapy trial results. It has a tumor immunology section and recent landmark trial results incorporated, with FDA approvals highlighted. The chapters are organized by tumor type, pathway, and drug name. It’s small enough to fit in a lab coat pocket, or the eBook can be downloaded for even more convenience. The digital version is 408 pages long and published by LWW; Second edition (July 18, 2018). The language is English and the ISBN is 978-149638913.

Category: Medical Book

Description

Handbook of Targeted Cancer Therapy and Immunotherapy, 2nd edition (PDF Book)

by Daniel D. Karp (Editor), Gerald S. Falchook MD MS (Editor), Joann Lim (Editor)

Introduction:

The “Handbook of Targeted Cancer Therapy and Immunotherapy, 2nd Edition” is an essential resource for oncologists, researchers, and other cancer care professionals. This comprehensive yet concise reference provides clinical trial results of over 190 targeted therapy and immunotherapy agents, making it a valuable tool for staying updated on the latest advancements in cancer treatment.

Key Features:

Expanded Immunotherapy Section: The book includes comprehensive information on immunotherapy trial results, reflecting the growing significance of this revolutionary approach in cancer treatment.
Tumor Immunology Focus: A dedicated section on tumor immunology is added, offering in-depth insights into this critical aspect of cancer therapy.
Incorporation of Landmark Trial Results: Recent landmark trial results are incorporated, ensuring that readers are informed about the most significant advancements in the field.
Highlighting FDA Approvals: The book emphasizes FDA approvals for targeted therapy and immunotherapy agents, giving readers a clear understanding of approved treatment options.
Organized Approach: Clinical challenges are addressed from multiple perspectives, with chapters organized by tumor type, pathway, and drug name, allowing for easy navigation and quick information retrieval.
Color-Coded Format: The book employs a color-coded, intuitive format, facilitating swift and straightforward access to information.
Portable Convenience: With its compact size, the handbook can fit in a lab coat pocket, providing an easily accessible reference during daily clinical practice. Alternatively, readers can download the eBook version for even more convenient referencing on smartphones or other devices.

Conclusion:

The “Handbook of Targeted Cancer Therapy and Immunotherapy, 2nd Edition” is an indispensable resource for oncologists, researchers, and cancer care professionals seeking to stay at the forefront of targeted therapy and immunotherapy advancements. With its comprehensive clinical trial results, focused immunotherapy section, and organization for quick information retrieval, this handbook equips readers with valuable insights into the latest cancer treatment approaches. Whether in print or eBook format, this handbook provides a convenient and up-to-date reference for approaching clinical challenges in cancer care from various angles, ensuring the best possible outcomes for patients.